AcenocoumarolReversible cerebral vasoconstriction syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1736卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56909-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：14 / 14

相关论文

共 50 条

[21] CiclosporinReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2017, 1648 (1) : 90 - 90
[22] LeuprorelinReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2020, 1830 (1) : 196 - 196
[23] CabergolineReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2024, 2030 (1) : 108 - 108
[24] TacrolimusReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2022, 1919 (1) : 559 - 559
[25] EtoricoxibReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2015, 1533 (1) : 209 - 209
[26] BupropionReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2021, 1844 (1) : 110 - 110
[27] TacrolimusReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2021, 1877 (1) : 372 - 372
[28] TocilizumabReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2019, 1752 (1) : 369 - 369
[29] Reversible cerebral vasoconstriction syndrome: case report
Oğuzhan Öz
Şeref Demirkaya
Semai Bek
Erdal Eroğlu
Ümit Hıdır Ulaş
Zeki Odabaşı
The Journal of Headache and Pain, 2009, 10 : 295 - 298
[30] PhenelzineReversible cerebral vasoconstriction syndrome: case report
Reactions Weekly, 2014, 1511 (1) : 36 - 36

← 1 2 3 4 5 →